These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35786050)

  • 1. Ursolic acid inhibits proliferation, migration and invasion of human papillary thyroid carcinoma cells via CXCL12/CXCR4/CXCR7 axis through cancer-associated fibroblasts.
    Cao X; He Q
    Hum Exp Toxicol; 2022; 41():9603271221111333. PubMed ID: 35786050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and function of CXCL12/CXCR4/CXCR7 in thyroid cancer.
    Zhu X; Bai Q; Lu Y; Lu Y; Zhu L; Zhou X; Wu L
    Int J Oncol; 2016 Jun; 48(6):2321-9. PubMed ID: 27082011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
    Qiao N; Wang L; Wang T; Li H
    Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CXCL12-CXCR4 axis promotes migration, invasiveness, and EMT in human papillary thyroid carcinoma B-CPAP cells via NF-κB signaling.
    Lin Y; Ma Q; Li L; Wang H
    Biochem Cell Biol; 2018 Oct; 96(5):619-626. PubMed ID: 29316404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulatory effects of trophoblast-secreted CXCL12 on the migration and invasion of human first-trimester decidual epithelial cells are mediated by CXCR4 rather than CXCR7.
    Zheng J; Wang H; Zhou W
    Reprod Biol Endocrinol; 2018 Mar; 16(1):17. PubMed ID: 29499763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL12-CXCR4/CXCR7 axis contributes to cell motilities of oral squamous cell carcinoma.
    Chen N; Jiang X; Wang J; Wu T; Cheng B; Xia J
    Tumour Biol; 2016 Jan; 37(1):567-75. PubMed ID: 26232325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells.
    Heinrich EL; Lee W; Lu J; Lowy AM; Kim J
    J Transl Med; 2012 Apr; 10():68. PubMed ID: 22472349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of CXCR4/CXCL12 signaling axis by ursolic acid leads to suppression of metastasis in transgenic adenocarcinoma of mouse prostate model.
    Shanmugam MK; Manu KA; Ong TH; Ramachandran L; Surana R; Bist P; Lim LH; Kumar AP; Hui KM; Sethi G
    Int J Cancer; 2011 Oct; 129(7):1552-63. PubMed ID: 21480220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression and biological function of chemokine CXCL12 and receptor CXCR4/CXCR7 in placenta accreta spectrum disorders.
    Long Y; Jiang Y; Zeng J; Dang Y; Chen Y; Lin J; Wei H; Xia H; Long J; Luo C; Chen Z; Huang Y; Li M
    J Cell Mol Med; 2020 Mar; 24(5):3167-3182. PubMed ID: 31991051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCR4, but not CXCR7, discriminates metastatic behavior in non-small cell lung cancer cells.
    Choi YH; Burdick MD; Strieter BA; Mehrad B; Strieter RM
    Mol Cancer Res; 2014 Jan; 12(1):38-47. PubMed ID: 24025971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CXCL12-CXCR4/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies.
    Daniel SK; Seo YD; Pillarisetty VG
    Semin Cancer Biol; 2020 Oct; 65():176-188. PubMed ID: 31874281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proinflammatory CXCL12-CXCR4/CXCR7 Signaling Axis Drives Myc-Induced Prostate Cancer in Obese Mice.
    Saha A; Ahn S; Blando J; Su F; Kolonin MG; DiGiovanni J
    Cancer Res; 2017 Sep; 77(18):5158-5168. PubMed ID: 28687617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis.
    Hernandez L; Magalhaes MA; Coniglio SJ; Condeelis JS; Segall JE
    Breast Cancer Res; 2011; 13(6):R128. PubMed ID: 22152016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
    Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
    BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCR7 is not obligatory for CXCL12-CXCR4-induced epithelial-mesenchymal transition in human ovarian cancer.
    Zheng N; Liu W; Chen J; Li B; Liu J; Wang J; Gao Y; Shao J; Jia L
    Mol Carcinog; 2019 Jan; 58(1):144-155. PubMed ID: 30259564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells.
    Luker KE; Lewin SA; Mihalko LA; Schmidt BT; Winkler JS; Coggins NL; Thomas DG; Luker GD
    Oncogene; 2012 Nov; 31(45):4750-8. PubMed ID: 22266857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of CXCR4 and CXCR7 for reduction of cell proliferation and invasion in human endometrial cancer.
    Long P; Sun F; Ma Y; Huang Y
    Tumour Biol; 2016 Jun; 37(6):7473-80. PubMed ID: 26678890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CXCR4 and CXCR7 in papillary thyroid carcinoma and adjacent tissues and their relationship with pathologic indicators of tumor aggressiveness.
    Cao X; Zhu J; Li X; Ma Y; He Q
    Endocr J; 2022 Feb; 69(2):189-197. PubMed ID: 34588386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profile analyze the molecular mechanism of CXCR7 regulating papillary thyroid carcinoma growth and metastasis.
    Zhang H; Teng X; Liu Z; Zhang L; Liu Z
    J Exp Clin Cancer Res; 2015 Feb; 34(1):16. PubMed ID: 25887589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug Design Targeting the CXCR4/CXCR7/CXCL12 Pathway.
    Xu D; Li R; Wu J; Jiang L; Zhong HA
    Curr Top Med Chem; 2016; 16(13):1441-51. PubMed ID: 26369824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.